PERSONALIZED APROACH TO POSTOPERATIVE CHEMOTHERAPY IN THE COMBINED MODALITY TREATMENT OF NON-SMALL CELL LUNG CANCER (CLINICAL CASE)
We present a clinical case of non-small cell lung cancer treated with personalized adjuvant chemotherapy. The expression levels of drug resistance genes, such as ABCC5, RRM1, ERCC1, TOP1, TOP2a, TUBB3 and TYMS in tumor tissue from non-small cell lung cancer were used as predictive markers. This case...
Saved in:
| Main Authors: | E. O. Rodionov, S. V. Miller, M. M. Tsyganov, O. V. Cheremisina, S. A. Tuzikov, N. V. Litvyakov, I. G. Frolova, S. A. Velichko, P. I. Lukyanenok, T. V. Polishchuk |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2016-07-01
|
| Series: | Сибирский онкологический журнал |
| Subjects: | |
| Online Access: | https://www.siboncoj.ru/jour/article/view/357 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A PERSONALIZED APPROACH TO ADJUVANT CHEMOTHERAPY FOR NON-SMALL CELL LUNG CANCER AFTER RADICAL SURGICAL TREATMENT BASED ON MOLECULAR MARKERS OF CHEMOSENSITIVITY
by: L. A. Efteev, et al.
Published: (2019-11-01) -
CHEMOTHERAPY IN COMBINED MODALITY TREATMENT FOR LOCALLY ADVAMCED NON-SMALL CELL LUNG CANCER
by: Е. L. Yumov, et al.
Published: (2016-02-01) -
Substantiation of Expressive Markers Use to Personalize Lung Cancer Chemotherapy
by: M. M. Tsyganov, et al.
Published: (2020-05-01) -
Personalized adjuvant chemotherapy for stage II–III non-small cell lung cancer
by: E. O. Rodionov, et al.
Published: (2024-01-01) -
mRNA expression of chemosensitivity genes as a predictor of response to neoadjuvant chemotherapy in non-small cell lung cancer
by: M. M. Tsyganov, et al.
Published: (2019-02-01)